Clinical diagnostic laboratory services and specialty testing

Ingenio Diagnostics specializes in a range of advanced diagnostic technologies, focusing on clinical laboratory services that include anatomic pathology, next-generation sequencing, molecular diagnostics, and immunoassays. Their expertise in these areas allows them to provide comprehensive diagnostic solutions that are essential for accurate disease detection and management. The integration of pharmaceutical, biotechnology, and contract research organization (CRO) services enhances their capabilities, ensuring that they deliver high-quality results that meet rigorous clinical standards.

The company emphasizes the importance of sample procurement in their diagnostic processes, which is critical for obtaining reliable and valid test results. By leveraging cutting-edge technologies such as next-generation sequencing and molecular diagnostics, Ingenio Diagnostics is positioned to offer innovative solutions that cater to the evolving needs of the healthcare industry. Their commitment to maintaining licensure and accreditation further underscores their dedication to quality and compliance in clinical diagnostics.

United States

Ingenio Diagnostics (ID), a Genesis Drug Discovery and Development (GD3) Member Company, combines experience in Pharmaceutical, Biotechnology, and CRO services with a clinical diagnostic laboratory's licensure and accreditation. We deliver clinical diagnostic laboratory services and specialty testing with the additional benefit of dedicated quality assurance & quality control division. Our highly-skilled team of scientists, clinical, and operations personnel have extensive experience analyzing a wide variety of patient specimen types, spanning multiple analytical platforms in many therapeutic areas.

Ingenio Diagnostics

Company Details